QRFPR

pyroglutamylated RFamide peptide receptor, the group of Peptide receptors

Basic information

Region (hg38): 4:121328642-121381059

Previous symbols: [ "GPR103" ]

Links

ENSG00000186867NCBI:84109OMIM:606925HGNC:15565Uniprot:Q96P65AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the QRFPR gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the QRFPR gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
24
clinvar
24
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 24 0 0

Variants in QRFPR

This is a list of pathogenic ClinVar variants found in the QRFPR region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
4-121329372-T-C not specified Uncertain significance (Nov 30, 2022)2345012
4-121329393-T-A not specified Uncertain significance (Jul 06, 2021)2234613
4-121329505-T-C not specified Uncertain significance (Oct 10, 2023)3150326
4-121329556-C-T not specified Uncertain significance (Aug 28, 2023)2622113
4-121329584-AT-A not provided (-)441009
4-121329627-T-A not specified Uncertain significance (Jan 31, 2024)3150335
4-121330434-A-G Uncertain significance (Sep 30, 2022)2173212
4-121330501-T-C not specified Uncertain significance (Jul 22, 2022)2369788
4-121332839-T-A not specified Uncertain significance (Oct 17, 2023)3150334
4-121332851-A-C Uncertain significance (Jul 01, 2017)493398
4-121332917-T-C not specified Uncertain significance (Jun 24, 2022)2228282
4-121332923-A-C not specified Uncertain significance (Aug 17, 2021)2347229
4-121332965-A-G not specified Uncertain significance (May 13, 2024)3311936
4-121332987-G-C not specified Uncertain significance (Feb 27, 2024)2378069
4-121336822-G-C not specified Uncertain significance (Jun 02, 2024)3311937
4-121340458-T-C not specified Uncertain significance (Mar 06, 2023)2458741
4-121340590-C-A not specified Uncertain significance (Jun 06, 2023)2516749
4-121340602-T-C not specified Uncertain significance (Mar 18, 2024)3311935
4-121364107-TGAGGTCCTGCGTTACAAGGGCAGGAATCAGTAGGATGGCTCTGTATGAATACGGGTGTGGTAACATCATGCCTACAGTCCAGGGTGGCCTGGAAAAACACTCTACAATTGGGCATGTCTTTCAAAGCATGAGCCTTGCAAAGCATGAAAGAGTTTTGTGGAATGTTACCGAATGTAACAGAAAAAACTTGAATGGAATGAGAGAAAGGGGTTCTAAGGCATGTTAATTGAAATGTCTAAAAACTTTTGGCTGGGCATGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGCGGGTGGATCACAAGGTCAGGAGATCGAGACTATCTTAGCTAACATGGTGAACCCCTGTCTCTACTAAAAATACAAAAACAAAATTAGCCAGGCATGGTGGCGGGTGCCTATAGTCCCAGCTACTCTGGAAGCTGAGGCAGGAGAATGGTGTGAACCTGGGAGGCGGAGCTTGCTGTGAGCCGAGATTGCGCCACTGCACTCCAGCCTGGGCCACAGAGCGAGACTCCATCTTAAAAAAAAAAAGAAAAGAAAAAAGAAAAAGAAAACTTTTTGAAATATGTAATTAAAGATTAAAATTATTTTACGTTAGTGCTGGTCACTGGACTAAATTTCTTTGAGTTTGACACTGTACCTAGCCTGGTCTTTCTGGAGTACTAGGATGTATTCAGCCTACAAGAGTAAAGGGAAAGGTAGAGGATATGAGATAGTAAAAACATAGAATAAACCAAAAGATTAACCACCATAGCAGTAAAAAGCAATTCGATTTAATAAGCAGGTCTTTGTTTACTACTGGAGAGAAGTAGAGTCACATTCATGGCCCAGCCCTGGAGATTCAGGAATTCTTTATGCTGAGCTCCATACAGCTGTTTTTTGGGGTTCCATTTAAGTCTCCATGAGACCTACTAGTTACTGTCTTTAAATTTAAAAGAGATCCCTCTCTTCATCATTGCTACAAAATAGCCTTCCCATAATTCTAATTATTTTAAGTAAGTTGAATCTTTTTTCTTGCAAAACTACAATATTCACAAAAGATAAATACAATCTCATCCTTATACACAACACAAAAAAGGAATATAACTGATTCCTAAAAAGCTGTGGGCGGATCATGAGGTCAGGAGATCGAGACTATCCTGGCTAACACAGTGAAACCTCGTCTCTGCTAAAAATACAAAAAAATTGGCTAAGCATGGTGGCAGGCGCCTGTAGTCCCAGCTACTCGGGAGGCTGAGGCAGGAGAATGGTGTGAACCTGGGAGGCAGAGCTTTTAGTGAGCCGAGATCACGCCACCGCACTCCAGCCTGGGCAACAGAGCGAGACTCCATCTCAAAAATAATAATAAATAAATTAATTAATTAATTAAATTATATATATAATATATATAATATATATTATATATATTATATATAATATATATTATATATAATATATAATATATATTATATATAATATATATTATATATATTATATATATATAATATATATATTATATATATTATATATTATATATATATTTTATATATTATATATTATATATATTTTATATATTATATATATATATAAAACTAGTGTCATCTCTTTCCCAGAAATCACTGTTTGGATCAGGTTCATATTGACACTTAGATTTTGATCCAGTAAAATTCATCGTAATAAGAATAAATCCTTTATTGTTTGTAGACATTACAGTAAAGAATTTTTTTAAAACCAAGCATGTAGTTTTATCTGTAGAATAGCTTCATGGTTACTTTTACACTTGAGCCAATACAGACTTCTATGAATATGTATATATATTAGGGGCCTCTGCATTAGTAGACTTGCGGGCTGGGTTACTTATAGTCAGTGTGCAAGAGTCAATTTTCACAAAGATCTATGAGGAAAAGATCATGGCAGACTTTCACTACAAAAATTTGTCTTCCAGGTCTCAAACTAGTACCTGAGTTCGAGGGGTGGAACTGCTGAAGGCACCCCTGCACAAACAGGGCCAAAGCAGGTGGTGAAGCATAATTCACTGCAGAAAGTGAAATTCTTCCCCGTCAGTATAACCAGTGTGGTTAAAAACCCAACACTGAAGCAGACTGGTTGGGTCAAAGCCTGGCACCAGTATTTCCAGTCTATATGAGCTTGGGCATTTTACTTACTATAAAAAATTAAGATTTTTTTTTAAAGGCTACAAATTCCATTACTTTCTGTGAGCTCTCTAAAACATGATTTTGCCACTTGTCACATCAAGTGGAGGAATCTGTTTCCCTATTCTTTGAATCTGGGCCAGTGATGTGACTTGCTTTATCACAGAAGTAACATTTGTGTGACATTCAATCCTAGGTCTTGAAAGATTCTGGTGCTTCTATTCTCTCTCTCTCTTTCAGAATATGGTGCCTCCACACAAAGAATTCTGGGTATCCAACCGAAAGAGGAAACCATGTGGGACAGGGATGGCCTGGCCCTTGCTGAGGTCACCAGTTAAAACAATGAGCCCCTATGAGGTCACCAGATAGATGTAGCACTGAGAGTGAACAAAGTGAGACTAGCAGAAGAACCATCCAGATGAGCCAACCTGAAATTGCTGACCTGTAGAATCATGAATGATTCTTTAATCACCTAAATTTTTTGTGATTTGCTGTGCAGAATAGCTAATTAATACACTAACACCTCTCTGAGCCTCCATTTTCTCATCTGTAAAATGAGGATAATATTATATTTGGCACATAGTAAGCTCTATGTTAAGACTTTGGTATCCATTTTCATATTATTATTTCCACTTCTCTGCAGTGCATAGCAAGGCTCTAGTGCCCAGGATTGCCCAGATCTCAGCAAGTCTGCACCAGCATCACAGGAAAGTCAAAGGACAATATTCATACACCTGACATCATTGTTTCACGGTCACTCTCACCCTGGTGTCCAAATTGAGGTGCCGTCATGTACCTCTTTAGGCTATGAACTAAACAGCAAGAATGTCAACAAGATAACTGGCTGCACATGTCCATTATCAAGGGAGGTTCCGCTGGGGTGGGATAGGGAGTCAGGCACACAGGGGTTGAGAAAAGTTGTCTTAAATTACGAGACAGAGGCAGGGGACAGTGGGACCGCTTCCTAGGAACATTGGTGTTGCAACATTGTGCCCACAGTCTGGGTGGCCTGGAAAGACACATGAGCCTTGAAAGGAACTACAAAATCAGCTTCAGTCCCAACAAATTTTTTTTAACACCACTTTATCCTCCTCTAGAGATGTATTATTGCTTCTGAAATAAATGAAAGCAGCACCCTTTTCTGTTTTCTGAGTACAAATGATTAGTTTGAATCCTCATAGTTTGAGCATAAAAGTAATTCTTTTCATGTAAATTGTATTTATGTGAAATAACTACTTCATTGTATTTTATCATAAATAAACTATAATGGACCTGGTTTTTACAGTTGCTTTGTAAAAGTACACACCAAATATATTTGAGATATTACTAACAGTGCAACAAGTTTTTAAAAAGTTCTCTAATGTCCTTATTGTCTCTAAAATTATTCTACACACAAATGTAGCTAACACTTTAAGTAGCAGAACTTCGAATATGTGAACAACAATTATAGTTTCCTTTCTTTGGATACCCTCTAGGTGCCTGGTCCTTTTGACACCTGGGGTCATTCATTGTCACAGCAACACTGTAAGGTGGGAATAAGTTTTCCTAAGTTTACATATTAGGACACCAAAGCAAAGAGAAATTAATACCACAGTCAAACATTATCTTTGCCAACCTACAACATTTGCAGATTTTTTTTTTTTGGAGAAAGTAGTAAGGATTTTTATTGTCAAAACAAGAGATCACAATAGAAGACACAAATAAATTAATTCTTATAATTTTAGACTCCAGGGCCTCTCTATGGAAAGGCCAGCTTCTTACACAGACAAGGTACTATCCAAAACAAAAAATTGGGTATTTGAGACAGTATTCAAGACAAAAACTGAACTTGTACACAGTGAGGAGAAATAAAAAAGTGGTTTCCCTATTTCCCTCCCTCAGTAAGGTTATGTATTGCATAAAGGGATGAGGCTCATTTTGGTGAAAAATGCTTTCATACAGAAAATTTTGAATTCATTCTCCTCCTCCCACAGACGTTCCAGGCCCTGACCTGAACAAGGAAATCAAAATAAGGTAACACCACTGGCTCCACATAAACCTCAAGACTATAATCTAACTGTACCTACCATCTCCTTTACTTTAAAAAAGTTTAAGTCCATTTACCTATACCAAGTCAGTAGACTGAATTTTCTCTCTTAGGAAGCTTTTAACCAAATTGCAGCTAAATTAATCTCACTTTAAAGTGCAAGAAAGGCTCTGCTAGACTAGTGTTTGTTCTGTGGCATAGAAAGAGAAGCATGCCTCCCCTGGCACTGGCCTAAGAGGCCCCACATGAAGAACTGGTTGCAGGACAGTGATCCATTAGGTCTACCAAAAAGCAGGGGGACTCAAGGTTCAGCCTAGAAACAGGGGTCCCTGCCAAGTCTGGTTTTACCTATACCCAGGTCCCAAACAAATCTTGGGTCCCCTTACTGATAAGGCTGGAGCACAGCACCAGCCATCAACAGGGCCAGAGTC-T Gestational diabetes mellitus uncontrolled not provided (-)156931
4-121380320-T-C not specified Uncertain significance (Dec 27, 2023)3150330
4-121380400-A-C not specified Uncertain significance (Oct 05, 2023)3150329
4-121380426-C-A not specified Uncertain significance (Mar 29, 2022)2232881
4-121380491-C-T not specified Uncertain significance (Aug 16, 2021)2396419
4-121380514-T-G not specified Uncertain significance (Sep 16, 2021)2250059
4-121380533-C-G not specified Uncertain significance (Dec 19, 2023)3150328

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
QRFPRprotein_codingprotein_codingENST00000394427 651748
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
7.86e-110.076312543323131257480.00125
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.1572262330.9710.00001062828
Missense in Polyphen3440.6140.83715531
Synonymous-0.5889386.11.080.00000391834
Loss of Function0.1741616.80.9549.63e-7177

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.009200.00914
Ashkenazi Jewish0.0005960.000595
East Asian0.0009240.000925
Finnish0.0001400.000139
European (Non-Finnish)0.0004560.000440
Middle Eastern0.0009240.000925
South Asian0.002510.00242
Other0.0006640.000652

dbNSFP

Source: dbNSFP

Function
FUNCTION: Receptor for the orexigenic neuropeptide QRFP. The activity of this receptor is mediated by G proteins that modulate adenylate cyclase activity and intracellular calcium levels. {ECO:0000269|PubMed:12960173}.;
Pathway
Signaling by GPCR;Signal Transduction;Orexin and neuropeptides FF and QRFP bind to their respective receptors;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (q) signalling events;GPCR downstream signalling (Consensus)

Recessive Scores

pRec
0.0791

Intolerance Scores

loftool
0.917
rvis_EVS
1.62
rvis_percentile_EVS
96

Haploinsufficiency Scores

pHI
0.0457
hipred
N
hipred_score
0.190
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.000827

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyHighMediumHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Qrfpr
Phenotype
skeleton phenotype;

Gene ontology

Biological process
G protein-coupled receptor signaling pathway;neuropeptide signaling pathway
Cellular component
plasma membrane;integral component of membrane
Molecular function
G protein-coupled receptor activity;neuropeptide Y receptor activity